Home › Merck's grass pollen allergy drug wins U.S. approval
 

Keywords :   


Merck's grass pollen allergy drug wins U.S. approval

2014-04-15 03:27:19| Biotech - Topix.net

Merck & Co said the U.S. Food and Drug Administration on Monday approved its grass pollen allergy drug Grastek, becoming the second such immunotherapy treatment to be given the go-ahead in recent weeks.

Tags: drug approval wins grass

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
06.10Tropical Storm Milton Public Advisory Number 5
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Graphics
More »